Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-10-16

Clinical Trial Update: Effect of Vitamin D Treatment in Primary Hyperparathyroidism [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 trial results evaluating Vitamin D therapy in primary hyperparathyroidism have been completed, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: University of Aarhus | Conditions: Vitamin D Deficiency, Primary Hyperparathyroidism | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2013-10-16